Mung Bean Sprouts / mTOR Cancer Research Results

MBS, Mung Bean Sprouts: Click to Expand ⟱
Features:

Mung Bean Sprouts - Vigna radiata Sprouts

Alternative Names: Mung bean sprouts, green gram sprouts, Vigna radiata sprouts

Type: flavonoid-rich functional food

Source: Germinated seeds of Vigna radiata.

Active Constituents: Mung bean sprouts contain flavonoids including vitexin and isovitexin, phenolic acids, GABA, proteins, peptides, vitamins, minerals, and other antioxidant phytochemicals. Sprouting substantially alters the phytochemical and nutritional profile compared with unsprouted mung beans.

Function: Mung bean sprouts exhibit antioxidant, anti-inflammatory, metabolic, and cytoprotective effects. Sprouting can increase the availability of bioactive phenolic and flavonoid compounds and modify carbohydrate, protein, and antinutritional components. Reported biological effects include modulation of oxidative stress, inflammatory signaling, glucose and lipid metabolism, and cellular stress responses.

Cancer: Preclinical evidence suggests antiproliferative and antioxidant effects from mung bean sprout extracts and constituent flavonoids, including vitexin and isovitexin. Potential mechanisms include modulation of oxidative stress, inflammatory signaling, apoptosis, and cell proliferation. Direct clinical anticancer evidence for mung bean sprouts is not established.

Alzheimer's Disease: Evidence is limited and primarily indirect or preclinical. Antioxidant, anti-inflammatory, and metabolic effects of mung bean sprouts and their flavonoid constituents may be relevant to neuroprotection, but efficacy for Alzheimer's disease has not been established.

-"Phenolic acids in mung bean can be divided into hydroxycinnamic acids (p-coumaric, ferulic, sinapic, and caffeic acid), hydroxybenzoic acids (gallic, syringic, protocatechuic,vanillic, and gentisic acid), and caffeoylquinic acid isomer (chlorogenic acid)"
-"Flavonoids detected include flavones (vitexin, isovitexin, isovitexin-6″-O-α- L -glucoside, dulcinoside, and luteolin), flavonols (quercetin, myricetin, and kaempferol), and flavanols (catechin), and several mung bean flavonoids are also found in bound forms, such as quercetin, luteolin, and kaempferol."
-"The content of each phenolic compound in mung bean is greatly affected by the cultivars, the place where they grow, as well as the extraction and analytical methods. Generally, vitexin (12−300 mg/100 g) and isovitexin (3−532 mg/100 g) are usually the most abundant phenolic compounds detected, and are regarded as the major bioactive compounds in mung bean."
-"several polyphenols can only be detected in seed coat rather than cotyledon, including vitexin, isovitexin, vanillic acid, and catechin"

Mung Bean Sprouts — edible sprouts produced by germination of Vigna radiata seeds and used primarily as a food and functional-food source of polyphenols, peptides, phenolic acids, vitamins, minerals, and other phytochemicals. They are classified as a whole-food botanical/functional food rather than a standardized drug or extract; the standard abbreviation used here is MBS. Major polyphenols associated with mung bean include vitexin and isovitexin, although germination substantially changes the phenolic profile and can increase other compounds such as rutin, isoquercitrin, isorhamnetin, caffeic acid, and related apigenin derivatives. Composition depends strongly on cultivar, seed fraction, germination duration, and processing.

Primary mechanisms (ranked):

  1. Induction of apoptosis and growth inhibition in cancer cells, with activation of tumor-suppressive and apoptotic signaling.
  2. Cell-cycle slowing/arrest, particularly G0/G1 arrest associated with increased p53, p21, and p27 in responsive cancer-cell models.
  3. Immunomodulation, including increased tumor-associated TNF-α and IFN-β signaling and increased IFN-γ with reduced IL-4 in peripheral immune-cell experiments.
  4. Polyphenol-mediated antioxidant and anti-inflammatory activity, principally relevant to normal-tissue and neuroprotective effects rather than established cancer-cell killing.
  5. Modulation of protein aggregation, oxidative stress, neuroinflammation, cholinergic signaling, and autophagy in neurodegenerative models, although much of this evidence derives from mung-bean extracts or individual constituents rather than sprouts themselves.

Bioavailability / PK relevance: Mung bean sprouts are consumed as a food, and no clinically validated anticancer pharmacokinetic exposure target has been established for the whole sprout. Vitexin, isovitexin, phenolic acids, and related compounds undergo intestinal absorption and extensive metabolic transformation, while peptides and larger phytochemical complexes are substantially altered during digestion. Sprout composition is not standardized, making exposure substantially less predictable than with a purified compound or standardized extract.

In-vitro vs systemic exposure relevance: The strongest direct anticancer study of mung bean sprouts used concentrated methanolic extracts with cancer-cell IC50 values of approximately 13–14 mg/mL. Such whole-extract concentrations should not be interpreted as achievable systemic concentrations after ordinary oral consumption. Potential gastrointestinal luminal exposure may be considerably greater than circulating exposure, but there is no evidence that dietary consumption reproduces the systemic concentrations used in these cancer-cell experiments.

Clinical evidence status: Cancer evidence is preclinical, dominated by cell-culture studies with limited supporting animal evidence for mung bean preparations; there are no established human anticancer trials demonstrating therapeutic efficacy of mung bean sprouts. Neuroprotective and Alzheimer-related evidence is also predominantly preclinical, with recent animal and mechanistic studies involving Vigna radiata extracts or seed-coat extracts rather than ordinary dietary sprouts. Mung bean sprouts should therefore be regarded as a functional food with experimental anticancer and neuroprotective mechanisms, not a clinically validated cancer or Alzheimer treatment.

Safety: Nutritionally, mung bean sprouts are generally used as food; however, raw sprouts have an important microbiological safety constraint because warm, humid sprouting conditions can amplify pathogens including Salmonella, pathogenic E. coli, and Listeria. Thorough cooking substantially reduces this foodborne-infection risk and is particularly relevant for immunocompromised individuals.

Cancer Mechanisms

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation
1 Apoptosis ↑ ↔ G Selective cytotoxicity and apoptotic cell death Direct mung bean sprout extract experiments showed dose- and time-dependent apoptosis in HeLa and HepG2 cells with substantially lower cytotoxicity toward tested normal cells.
2 p53 p21 p27 tumor-suppressor axis ↑ ↔ G Growth suppression and cell-cycle control p53, p21, and p27 were induced in HeLa cells; regulation was cell-type dependent, with p53 predominating in HepG2 cells.
3 G0 G1 cell-cycle arrest ↑ ↔ G ↓ proliferation HeLa cells showed a substantial increase in the G0/G1 population after treatment with concentrated mung bean sprout extract.
4 TNF-α and IFN-β antitumor signaling ↑ ↔ G Pro-apoptotic and antiproliferative cytokine signaling Treated HeLa and HepG2 cells secreted increased TNF-α and IFN-β; these signals may contribute to apoptosis and cell-cycle inhibition.
5 Cell-mediated immune response ↑ IFN-γ ↑; IL-4 ↓ G Th1-skewed immunomodulation Mung bean sprout extract increased IFN-γ and suppressed IL-4 in peripheral blood mononuclear-cell experiments, consistent with enhanced cellular immune polarization.
6 Phenolic and flavonoid signaling ↓ proliferation (context-dependent) ↑ cytoprotection G Antiproliferative and antioxidant activity Vitexin, isovitexin, phenolic acids, and other constituents contribute biologically, but effects attributed to isolated compounds should not automatically be assigned quantitatively to whole sprouts.
7 Oxidative stress regulation ↔ (context-dependent) ROS ↓ G Antioxidant protection Antioxidant activity is well supported for mung bean preparations, but direct ROS elevation is not established as a principal mechanism of mung bean sprout-induced cancer-cell killing.
8 Clinical Translation Constraint ↔ ↔ Limits therapeutic extrapolation Key cancer experiments used concentrated extracts near approximately 13–14 mg/mL IC50; these exposures are not representative of systemic levels after dietary consumption. No human anticancer efficacy trials establish a therapeutic dose.

P: 0–30 min    R: 30 min–3 hr    G: >3 hr





Alzheimer's disease relevance: Mung bean has meaningful but still preclinical neuroprotective evidence. Polyphenols associated with mung bean, including vitexin, isovitexin, ferulic acid, sinapic acid, and other germination-dependent phenolics, have been linked to reduced amyloid-related toxicity, oxidative stress, neuroinflammation, and tau-associated pathology. Recent Vigna radiata extract studies in rodent Alzheimer models report improved cognition and reductions in inflammatory and oxidative markers, while mung bean coat extract has been shown to activate AMPK-dependent autophagy and reduce Aβ and tau-associated protein aggregation in experimental models. These findings strengthen the biological plausibility of mung bean-derived neuroprotection, but they should not be interpreted as proof that ordinary mung bean sprouts treat Alzheimer's disease because sprout-specific clinical studies are absent.

Alzheimer's Disease Mechanisms

Rank Pathway / Axis Modulation Primary Effect Notes / Interpretation
1 Aβ accumulation and amyloidogenesis ↓ Reduced amyloid-related toxicity Mung bean-derived extracts and constituent literature support reduced Aβ-related pathology; direct evidence from ordinary sprouts remains limited.
2 AMPK autophagy axis ↑ Enhanced clearance of aggregation-prone proteins Mung bean coat extract activated AMPK-dependent autophagy and reduced disease-associated protein accumulation in experimental AD and PD models.
3 Tau pathology ↓ Reduced toxic protein aggregation Preclinical constituent and extract data support reduced tau-associated pathology and aggregation.
4 Neuroinflammation ↓ Reduced inflammatory neuronal injury Animal studies report reductions in TNF-α, IL-1 family signaling, and related neuroinflammatory markers after Vigna radiata extract treatment.
5 Oxidative stress ROS ↓ Neuroprotection Reduced lipid peroxidation and nitric oxide with increased endogenous antioxidant defenses have been reported in animal models.
6 AChE and cholinergic signaling AChE ↓ Preservation of cholinergic neurotransmission Recent whole-extract animal studies reported anticholinesterase activity; direction should be distinguished from some older constituent-level reports with differing experimental contexts.
7 Cognition and memory ↑ Improved behavioral performance Improvement has been reported in rodent Alzheimer models, but no clinical efficacy has been demonstrated in humans.
8 Translation Constraint ↔ Limits clinical inference Most evidence involves purified polyphenols, seed or coat extracts, or experimentally enriched extracts rather than conventionally consumed mung bean sprouts.


mTOR, mammalian target of rapamycin: Click to Expand ⟱
Source: HalifaxProj (inhibit)
Type:
mTOR (mechanistic target of rapamycin) is a central regulator of cell growth, proliferation, metabolism, and survival. It is a serine/threonine kinase that integrates signals from nutrients, growth factors, and cellular energy status.
mTOR promotes protein synthesis and cell growth by activating downstream targets such as S6 kinase and 4E-BP1. In cancer, this pathway can become hyperactivated, leading to uncontrolled cell proliferation.

mTor Inhibitors:
-rapamycin (Sirolimus): classic natural product mTOR inhibitor
-Curcumin
-Resveratrol
-Epigallocatechin Gallate (EGCG)
-Honokiol
Scientific Papers found: Click to Expand⟱
7824- MBS,  IVT,  VT,    Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review
- Review, AD, NA - Review, Stroke, NA - Review, Park, NA
*neuroP↑, *Aβ↓, *p‑tau↓, *ROS↓, *Inflam↓, *AChE↓, *BBB↑, *memory↑, *hepatoP↑, *Imm↑, *hyperG↓, *AntiCan↑, *eff↑, *Stroke↓, *BACE/β-secretase↓, *PI3K↓, *Akt↓, *mTOR↓, *Dose↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

hyperG↓, 1,   ROS↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   mTOR↓, 1,   PI3K↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

Imm↑, 1,   Inflam↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

AChE↓, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 1,   BACE/β-secretase↓, 1,   p‑tau↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

Dose↓, 1,   eff↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 1,   hepatoP↑, 1,   memory↑, 1,   neuroP↑, 1,   Stroke↓, 1,  
Total Targets: 19

Scientific Paper Hit Count for: mTOR, mammalian target of rapamycin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:464  Target#:209  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page